Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cow's milk powder is an investigational therapeutic agent used in oral immunotherapy (OIT) for the treatment of cow's milk allergy. Developed and studied extensively by Johns Hopkins University in collaboration with the University of North Carolina, this approach involves the oral administration of gradually increasing doses of standardized milk proteins, primarily casein and beta-lactoglobulin. The treatment aims to induce clinical desensitization by modulating the immune system's IgE-mediated response, thereby increasing the threshold for allergic reactions upon accidental exposure. The material used in these clinical trials is typically a standardized, organic, nonfat dry milk powder prepared specifically for therapeutic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cow's milk powder.